Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03274414 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03274414: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03274414 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03274414, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is being done to test a new treatment plan for large tumors in the sinus or nasal cavity that will include endoscopic surgery plus chemotherapy and proton-beam radiation therapy.
Interventions
- DRUG Cisplatin
- DRUG cisplatin and etoposide
- RADIATION Adjuvant Proton Radiotherapy
- PROCEDURE Endoscopic Resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2023-01-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03274414
The ClinicalTrials.gov registry entry for NCT03274414 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cisplatin is the first listed.
NCT03274414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03274414 about?
NCT03274414 is a clinical study titled "A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages". This study is being done to test a new treatment plan for large tumors in the sinus or nasal cavity that will include endoscopic surgery plus chemotherapy and proton-beam radiation therapy.
What is the current status of trial NCT03274414?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2017-09-01. Estimated completion is 2023-01-13.
What interventions are being tested in trial NCT03274414?
The interventions under investigation include: Cisplatin (DRUG), cisplatin and etoposide (DRUG), Adjuvant Proton Radiotherapy (RADIATION), Endoscopic Resection (PROCEDURE).
Who is sponsoring clinical trial NCT03274414?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.